Xstrahl systems are used for a variety of research and clinical applications. We look into some of those uses in detailed user spotlights.
Providence Cancer Center
Immunotherapy has become the most promising advancement in cancer treatment. One of the institutions leading the advancement of this type of research is the Earle A. Chiles Research Institute at Providence Cancer Center.
Queen’s University Belfast
The Radiobiology Research Group from the Centre for Cancer Research and Cell Biology at Queen’s University Belfast published a series of articles using SARRP to explore different translationally focused experimental approaches.
Dr John Glees
The Xstrahl 150 is perfectly suited to treating a range of superficial and benign conditions thanks to its versatile design offering both orthovoltage and superficial treatment techniques in one system. Dr John Glees takes advantage of the system’s adaptability to treat a range of non-melanoma skin cancers and dermatological conditions such as Dupuytren’s and Ledderhose.
The Xstrahl 100 is perfectly suited for the treatment of superficial skin cancers, and with Australia recording skin cancer rates of 2 in 3 people, the need for an effective and versatile treatment method is needed. With a rise in cosmetically focused patients, Just Skin Treatment Clinic have partnered with the Xstrahl 100 to deliver highly beneficial results.
With skin cancer being the most common type of cancer in the USA the need for an effective and versatile treatment method is a necessity for many skin cancer centers. The Xstrahl 100 is perfectly suited for the treatment of superficial skin cancers, as used by the SCARS center in California.
Léonard de Vinci Centre
Non-melanoma skin cancers (NMSC) are the most commonly diagnosed cancers in the world. Despite their relatively low malignant potential and mortality rate, NMSC are associated with a high morbidity and substantial treatment cost, and they significantly affect patient quality of life.
Vishnevsky Clinical Hospital
Interview with the radiotherapy department chief specialist and highest category radiologist, Dr. Anatoly Aleksandrovich Litvinov.
University of Pennsylvania
The University of Pennsylvania has been using SARRP for 10 years. Learn about the exceptional research they’ve been doing from Dr. Costa Koumenis, Professor and Vice Chair for Research of the Department of Radiation Oncology, who recently shared about their research and its impact as part of a SARRP panel.